在布鲁加达综合征中R893C NaV1.5突变的表征
Szabolcs Gaal1,2,3, Beata Meszaros1,3, Julianna Volko1,3
1Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Frontiers in cardiovascular medicine
|March 9, 2026
概括
在SCN5A基因中的R893C突变导致心脏通道 (NaV1.5) 的功能丧失,可能导致布鲁加达综合征 (BrS) 和心脏突然死亡.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 布鲁加达综合征 (BrS) 是一种遗传性疾病,增加了心脏突然死亡的风险.
- SCN5A基因突变,特别是在NaV1.5通道中,是BrS的主要原因.
- 在SCN5A中893残留物附近突变的功能影响以前是未知的.
研究的目的:
- 为了研究在一个BrS患者中发现的SCN5A R893C突变的功能后果.
- 确定R893C突变是否与布鲁加达综合征表型相关.
- 了解保存残留物893在NaV1.5通道功能中的作用.
主要方法:
- 用于引入R893C突变进入SCN5A基因的局部导向突变发生.
- 这些变体表达在中国仓鼠卵巢 (CHO) 细胞中.
- 采用全细胞补丁电生理学来测量电流 (INa).
主要成果:
- R893C突变显著取消了NaV1.5电流 (INa),表明功能丧失.
- 突变减少了通道激活,并改变了失活曲线,但没有改变失活动力学.
- 滴硫醇部分恢复了功能,这表明二硫化物桥梁形成有助于功能丧失.
- R893H突变也废除了INa,强调了893.3残留物的重要性.
结论:
- 在SCN5A中的R893C突变导致NaV1.5通道的严重功能丧失.
- 这种突变可能会导致受影响个体的布鲁加达综合征表型.
- 这些发现有助于更好地了解BrS病原体,并确定NaV1.5通道病变的潜在治疗点.
相关概念视频
Cardiomyopathy I: Introduction and Classification
741
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
741
Dysrhythmias IV: Characteristics of Bradyarrhythmias
714
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
714
Cardiomyopathy III: Hypertrophic Cardiomyopathy
602
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
602
Mechanism of Cardiac Arrhythmias
2.5K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.5K
Acute Coronary Syndrome III: Diagnostic Studies
357
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
357
Cardiomyopathy IV: Restrictive Cardiomyopathy
702
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
702


